New York City-based Ludwig Cancer Research Institute named Pat Morin, PhD, its new deputy scientific director July 12.
Dr. Morin most recently served as executive director for strategic alliances at the Philadelphia-based Abramson Cancer Center at the University of Pennsylvania since 2016.
Chi Van Dang, MD, PhD, Ludwig Institute's scientific director, said Dr. Morin is "perfectly suited" for the new role.
"Not only is he an accomplished cancer researcher, but he also has a demonstrated flair for catalyzing team science to tackle tough scientific questions, which was apparent in his able leadership of the [American Association for Cancer Research] Stand Up to Cancer initiative," Dr. Van Dang said. "His experience at the Abramson Cancer Center stimulating drug discovery through a partnership of four cancer centers will doubtless be an asset to Ludwig as we place a renewed emphasis on team efforts to address the most pressing problems of cancer care. I very much look forward to working with him to advance Ludwig's life-changing science."